ArticleCell death & disease2022

EGFL7 drives the evolution of resistance to EGFR inhibitors in lung cancer by activating NOTCH signaling.

Yubo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.